Suppressive effects of obesity on NK cells: is it time to incorporate obesity as a clinical variable for NK cell-based cancer immunotherapy regimens?

Canter, Robert J; Judge, Sean J; Collins, Craig P; Yoon, Daniel Jaeho; Murphy, William J

Canter, Robert J; Judge, Sean J; Collins, Craig P; Yoon, Daniel Jaeho; Murphy, William J.

Affiliation

Canter RJ; Surgery, UC Davis, Davis, California, USA.
Judge SJ; Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Collins CP; Dermatology, University of California Davis, Davis, California, USA.
Yoon DJ; Dermatology, University of California Davis, Davis, California, USA.
Murphy WJ; Dermatology, University of California Davis, Davis, California, USA wmjmurphy@ucdavis.edu.

J Immunother Cancer ; 12(3)2024 Mar 13.

Article de En | MEDLINE | ID: mdl-38485185

Sujet(s)
Mots clés

Clinical Trials as Topic; Immunotherapy; Killer Cells, Natural

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Cellules tueuses naturelles / Tumeurs Limites: Humans Langue: En Journal: J Immunother Cancer Année: 2024 Type de document: Article Pays d'affiliation: États-Unis d'Amérique Pays de publication: Royaume-Uni

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google